(Q37979706)

26 August 2017

title

Special aspects of the treatment of HIV-2-infected patients (English)

1 reference

26 August 2017

Ricardo Jorge Camacho

series ordinal

1

0 references

publication date

24 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

55

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

179-183

1 reference

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

26 August 2017

cites work

1 reference

HIV-2: the forgotten AIDS virus

21 January 2018

1 reference

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.

21 January 2018

1 reference

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

21 January 2018

1 reference

Genome organization and transactivation of the human immunodeficiency virus type 2.

21 January 2018

1 reference

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

21 January 2018

1 reference

Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors

21 January 2018

1 reference

In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors

21 January 2018

1 reference

Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.

21 January 2018

1 reference

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.

21 January 2018

1 reference

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

21 January 2018

1 reference

Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro

21 January 2018

1 reference

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen

21 January 2018

1 reference

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients

21 January 2018

1 reference

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

21 January 2018

1 reference

In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.

21 January 2018

1 reference

Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation

21 January 2018

1 reference

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000332025

1 reference

release_frinwphnbzeafn5trezhdpaodq

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/frinwphnbzeafn5trezhdpaodq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference